Fuminori Taniguchi
No ORCID on file
· 127 papers in corpus
· active 1999-2026
Study types
- article 90
- other 15
- review 10
- book-chapter 7
- editorial 1
Condition tags
- endometriosis 101
- endometrioma 19
- adenomyosis 16
- dysmenorrhea 15
- infertility 12
- chronic_pelvic_pain 5
- dyspareunia 4
- bowel_endometriosis 1
- bladder_endometriosis 1
Top journals
Frequent coauthors
- Takashi Harada 113
- Naoki Terakawa 43
- Tomio Iwabe 34
- Masao Izawa 28
- Yukihiro Azuma 25
- Takashi Uegaki 14
- Hiroaki KOMATSU 14
- Imari Deura 12
- Kazuomi Nakamura 12
- Kei Nagira 10
other
2023
AIM: This study aimed to compare introduced robotic-assisted hysterectomy (RAH) and skilled total laparoscopic hysterectomy (TLH) for the treatment of benign gynecological diseases. METHODS: Patients who underwent RAH or TLH by two surgeon…
article
2022
More than 10 years following the publication of "The General Rules for Clinical Management of Endometriosis: The second edition" in January 2010, the long-awaited third edition has arrived. The second edition represents the bible for endome…
article
2022
Uterine adenomyosis is an estrogen-dependent tumor and one of the most common benign diseases in sexually mature women. The frequency of endometrial cancer associated with adenomyosis has been reported to be 18%–66%. On the other hand, endo…
article
2022
Uterine adenomyosis is an estrogen-dependent tumor and one of the most common benign diseases in sexually mature women. The frequency of endometrial cancer associated with adenomyosis has been reported to be 18%–66%. On the other hand, endo…
book-chapter
2022
review
2022
BACKGROUND: Reproductive-age women occasionally face the pathological condition of adenomyosis, which is often concurrent with endometriosis. It is believed that endometriosis and adenomyosis increases the risk of obstetric complications. A…
article
2022
Abstract Background Endometriosis has been accepted as an estrogen-dependent disease for more than two decades. So far, estrogen modulators that targeting estrogen depletion in endometriotic lesions have been expected as the first option of…
other
2022
The pathogenesis of endometriosis has not been fully elucidated. We focused on the behavior of the ectopic endometrium, that is, the origin of the endometriotic lesion, before adhering to the peritoneal cavity. To observe lesion formation i…
article
2022
Endometriosis, which exhibits enigmatic pathological features such as stromal fibrosis and proliferation of ectopic epithelial cells, is known as a refractory disease. Mesenchymal stem cells modulate the fibrosis in stromal tissues through …
article
2021
PURPOSE: To evaluate the efficacy of two progestins, levonorgestrel intrauterine system (LNG-IUS) and dienogest (DNG), for adenomyosis. METHODS: = 81) groups as a controlled clinical trial for 72 months. Participants were classified by thre…
article
2021
Impact of 1.0 mg/Day Dienogest Treatment on Bone Metabolism Markers in Young Women with Dysmenorrhea
A low dose of dienogest (DNG) 1 mg/day is useful for treating dysmenorrhea in young women. However, the effect of DNG on bone turnover during bone growth and formation, rather than at maturity, is currently unknown even at low doses. We inv…
article
2021
Abstract Background: Endometriosis is an estrogen-dependent disease, and the role of estrogen is obvious because the symptoms associated with endometriosis often disappear after menopause, and GnRH agonists or progestin relieve the pelvic l…
other
2021
AIM: We aimed to describe the clinical presentation, operative or medical management, and postoperative recurrence of bladder endometriosis (BE). METHODS: We conducted a national survey to investigate BE cases from 2006 to 2016 in Japan. H…
book-chapter
2021
article
2021
Purpose: To verify the efficacy of the endometriosis fertility index (EFI) for predicting spontaneous pregnancy after surgery for endometriosis.
preprint
2021
Abstract Endometriosis, which exhibits enigmatic pathological features such as stromal fibrosis and proliferation of ectopic epithelial cells, is known as a refractory disease. Mesenchymal stem cells modulate the fibrosis in stromal tissues…
article
2020
Endometriosis results from the aberrant growth of endometrium outside the inner lining of the uterine cavity. Similar to humans, the primates also menstruate and hence, the primate models constitute the gold standard for studying the pathog…
article
2020
AIM: Endometriosis mostly affects the ovary but can also be present outside of the ovary including the pelvic peritoneum, intestine, urinary tract and lung. In case of ovarian endometriotic cyst, an increased risk of ovarian cancer, especia…
article
2020
The aim of this publication is to disseminate the clinical practice guidelines for the treatment of intestinal, bladder/ureteral, thoracic and umbilical endometriosis, already published in Japanese, to non-Japanese speakers. For developing …
article
2020
AIM: Tokishakuyakusan (TSS) is representative of popular Kampo medicines for Japanese women to treat dysmenorrhea, irregular menstruation and menopause. Current hormonal treatments and low-dose oral contraceptives (OCs) used as a first-choi…
article
2020
Abstract BACKGROUND: Endometriosis is an estrogen-dependent, inflammatory disease, and the role of estrogen is obvious because the symptoms associated with endometriosis often disappear after menopause, and GnRH agonists or progestin reliev…
article
2020
other
2019
BACKGROUND: Because of the increased number of diagnosed cases of endometriosis or adenomyosis resulting in infertility, many women require assisted reproductive technology (ART) to become pregnant. However, incidences of obstetric complica…
article
2019
article
2019
The cover image is based on the Original Article Tokishakuyakusan, a Kampo medicine, attenuates endometriosis like lesions and hyperalgesia in murine with endometriosis like symptoms by Fuminori Taniguchi, Kei Nagira, Naoko Tsuchiya et al.,…